Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate in non-melanoma skin cancers
NCT05315128Phase 2Completed
- Sponsor
- Zagazig University
- Start
- Jul 2020
- Primary completion
- Aug 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of methotrexate in non-melanoma skin cancer (NMSC) (2 arms), sponsored by Zagazig University. Primary endpoint: Reduction in size and number of tumors. Started Jul 2020; status: completed.
02
Drugs
methotrexate
03
Conditions
non-melanoma skin cancer (NMSC)
Beyond the preview
Go deeper on NCT05315128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05315128.